We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

129 hedge funds and large institutions have $312M invested in Viking Therapeutics in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $22.8M | Put options by funds: $5.27M

330% more capital invested

Capital invested by funds: $72.4M → $312M (+$239M)

135% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 17

21% more funds holding

Funds holding: 107 → 129 (+22)

9.79% more ownership

Funds ownership: 34.71% → 44.5% (+9.8%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

Holders
129
Holders Change
+22
Holders Change %
+20.56%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
34
Reduced
34
Closed
17
Calls
$22.8M
Puts
$5.27M
Net Calls
+$17.5M
Net Calls Change
+$17.1M

Top Buyers

1
BC
Boxer Capital
California
+$6.7M
2
GPP
Great Point Partners
Connecticut
+$5.78M
3
Millennium Management
Millennium Management
New York
+$5.71M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.94M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.18M

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.5M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.66M
3
Walleye Capital
Walleye Capital
New York
-$3.95M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.32M
5
IC
Ikarian Capital
Texas
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$41.2M +$5.71M +1,279,469 +41%
Vanguard Group
2
Vanguard Group
Pennsylvania
$31.3M -$24.2K -5,418 -0.2%
BC
3
Boxer Capital
California
$14.1M +$6.7M +1,500,000 New
BlackRock
4
BlackRock
New York
$12.7M -$537K -120,243 -8%
LCM
5
Laurion Capital Management
New York
$12.2M – – –
GPP
6
Great Point Partners
Connecticut
$12.2M +$5.78M +1,295,034 New
Two Sigma Investments
7
Two Sigma Investments
New York
$11.9M +$1.24M +278,865 +28%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$10.4M +$4.94M +1,105,600 New
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$8.94M +$4.18M +937,374 +6,760%
Renaissance Technologies
10
Renaissance Technologies
New York
$8.94M -$428K -95,800 -9%
Two Sigma Advisers
11
Two Sigma Advisers
New York
$8.9M +$180K +40,400 +4%
OCA
12
Octagon Capital Advisors
New York
$8.18M +$3.89M +870,500 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$7.72M +$1.55M +346,619 +73%
Group One Trading
14
Group One Trading
Illinois
$7.07M +$2.7M +604,295 +409%
CAM
15
Cormorant Asset Management
Massachusetts
$6.58M +$3.12M +700,000 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$6.15M +$5.67K +1,269 +0.2%
DTC
17
Deep Track Capital
Connecticut
$5.73M +$2.72M +610,083 New
IHAM
18
Integral Health Asset Management
New York
$5.64M +$2.68M +600,000 New
Morgan Stanley
19
Morgan Stanley
New York
$5.46M +$810K +181,522 +45%
DCM
20
DAFNA Capital Management
California
$4.9M -$138K -30,847 -6%
EI
21
EAM Investors
California
$4.65M +$2.21M +494,940 New
ECM
22
Endurant Capital Management
California
$4.07M +$1.93M +433,035 New
Simplex Trading
23
Simplex Trading
Illinois
$3.74M +$1.66M +372,508 +1,456%
DMKJ
24
David M. Knott Jr
$3.59M +$356K +79,818 +26%
HF
25
HRT Financial
New York
$3.57M +$1.69M +379,566 New
1
2 3 4 5

VKTX Hedge Fund Activity: Q4 2022 in Review

129 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q4 2022, worth a combined $312M — up 330% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new VKTX positions and 17 closed out — a net gain of 23 holders — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $6.7M. The largest seller was Balyasny Asset Management, cutting an estimated $11.5M.

  • 129 institutional investors held Viking Therapeutics (VKTX) as of Q4 2022, up from 107 in Q3 2022.
  • Funds reported $312M of Viking Therapeutics stock for Q4 2022, up 330% quarter-over-quarter.
  • 40 funds opened new Viking Therapeutics positions in Q4 2022 and 17 closed out, a net change of +23 holders.
  • The largest Viking Therapeutics buyer in Q4 2022 was Boxer Capital, an estimated $6.7M added.
  • The largest Viking Therapeutics seller in Q4 2022 was Balyasny Asset Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q4 2022.